SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus - Covid 19 Information Sharing Forum -- Ignore unavailable to you. Want to Upgrade?

To: XenaLives who wrote (5497)9/1/2024 11:25:17 AM
From: Valuepro  Respond to of 5936
 
FDA Drug Safety Communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings
fda.gov [From 2018.]

So, after 15 or 16 of these, I learn they are not good for people having chronic inflammation. But such side effects are certainly endurable if the contrast solution helps to resolve life-threatening issues, especially when they are used to guide highly delicate robotic surgeries.






To: XenaLives who wrote (5497)9/1/2024 11:40:46 AM
From: Stock Puppy1 Recommendation

Recommended By
Valuepro

  Respond to of 5936
 

Yeah - they poison you based on a B.S. claim that it improves the MRI results. ...




As to "poison", everything is a poison in the right dose.
Even dihydrogen monoxide.

When I go go an MRI, they take into account how many times previously that I've had contrast agents. They use it only when necessary.

As to "improves the MRI results", yes it does.

MRI is a fascinating topic - worthwhile to learn about.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News